We are live on ! Find out more

36 hedge funds and large institutions have $334M invested in Abivax in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more capital inflows, than outflows

Capital inflows: $41.1M | Capital outflows: $12.8M

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

20% more funds holding

Funds holding: 30 → 36 (+6)

3.35% more ownership

Funds ownership: 33.8% → 37.15% (+3.3%)

Holders
36
Holders Change
+6
Holders Change %
+20%
% of All Funds
0.52%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
12
Increased
9
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ABVX Hedge Fund Activity: Q1 2024 in Review

36 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in Abivax (ABVX) for Q1 2024, worth a combined $334M — up 47% from $228M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ABVX positions and 6 closed out — a net gain of 6 holders — while 9 added to existing stakes and 6 trimmed.

The largest buyer was Great Point Partners, adding an estimated $12.1M. The largest seller was Blackstone, cutting an estimated $3.24M.

  • 36 institutional investors held Abivax (ABVX) as of Q1 2024, up from 30 in Q4 2023.
  • Funds reported $334M of Abivax stock for Q1 2024, up 47% quarter-over-quarter.
  • 12 funds opened new Abivax positions in Q1 2024 and 6 closed out, a net change of +6 holders.
  • The largest Abivax buyer in Q1 2024 was Great Point Partners, an estimated $12.1M added.
  • The largest Abivax seller in Q1 2024 was Blackstone, an estimated $3.24M sold.

Based on aggregated 13F filings for Q1 2024.